Lapatinib in metastatic breast cancer

Author： Frenel J-S   Bourbouloux E   Berton-Rigaud D   Sadot-Lebouvier S   Zanetti A   Campone M  

Publisher： Future Medicine

ISSN： 1745-5057

Source： Women's Health, Vol.5, Iss.6, 2009-11, pp. : 603-612

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lapatinib in the management of breast cancer

By Hall Peter S   Bhosle Jaishree   Cameron David A  

Therapy, Vol. 6, Iss. 4, 2009-07 ,pp. : 553-568

Future Medicine

Access to resources Recommend Favorite

Current standards in the treatment of metastatic breast cancer with focus on Lapatinib: a review by a Central European Consensus Panel

By Steger Guenther G.  

Wiener klinische Wochenschrift, Vol. 122, Iss. 11-12, 2010-06 ,pp. : 368-379

Springer Publishing Company

Access to resources Recommend Favorite

A Single-Arm Phase II Trial of First-Line Paclitaxel in Combination with Lapatinib in HER2-Overexpressing Metastatic Breast Cancer

By  

Oncology, Vol. 79, Iss. 1-2, 2010-11 ,pp. : 129-135

Karger

Access to resources Recommend Favorite

Combination Therapy of Lapatinib and Capecitabine forErbB2-Positive Metastatic or Locally Advanced BreastCancer: Results from the Lapatinib Expanded AccessProgram (LEAP) in Central and Eastern Europe

By  

Oncology Research and Treatment, Vol. 34, Iss. 5, 2011-04 ,pp. : 233-238

Karger

Access to resources Recommend Favorite

Quality-of-life and quality-adjusted survival (Q-TWiST) in patients receiving lapatinib in combination with paclitaxel as first-line treatment for metastatic breast cancer

By Sherrill Beth   Di Leo Angelo   Amonkar Mayur M.   Wu Yun   Zvirbule Zanete   Aziz Zeba   Bines Jose   Gomez Henry L.  

Current Medical Research and Opinion, Vol. 26, Iss. 4, 2010-04 ,pp. : 767-775

Informa Healthcare

Access to resources Recommend Favorite